As a nutrition support pharmacist, you can help obese patients manage obesity as New Year’s resolutions kick in. Continue to emphasize lifestyle changes, and review medication lists for possible causes of weight gain (antipsychotics, steroids, etc). Updated Canadian guidelines recommend considering medications for patients with …
قراءة المزيدAs a nutritional support pharmacist, you will hear about using Rybelsus (semaglutide) for weight loss , it is now available in Egypt . Rybelsus will be the first ORAL GLP-1 agonist for type 2 diabetes, it's a tablet version of injectable Ozempic . Glucagon-like peptide-1 (GLP-1) is inactivated in the…
قراءة المزيدAs a pharmacy doctor, you will hear buzz about new injectable Mounjaro (tirzepatide), the first "twincretin" for type 2 diabetes . Think of Mounjaro as similar to a glucagon-like peptide-1 (GLP-1) agonist, BUT it’s also a glucose-dependent insulinotropic polypeptide (GIP) agonist. More twincretins are in the works. GL…
قراءة المزيدAs a nutrition support pharmacist, patients often ask you if their MEDICATIONS can cause weight gain. And alternatives to these medications may need to be considered, especially for patients who are overweight or obese with diabetes , etc... Atypical antipsychotics are notorious for causing weight gain, which might increase the risk of diabet…
قراءة المزيدMetabolic syndrome is a BIG problem and growing. It affects over 25% of adults and 4% of adolescents. It's also called "insulin resistance syndrome" or "syndrome X" or "dysmetabolic syndrome" and even has its own ICD-9 code (see table 1) . New treatment guidelines will focus even more attention on it... …
قراءة المزيدOne of the common misperception that prevent women from initiating oral contraceptive use is weight gain. Science hasn’t determined exactly why some birth control may lead to weight gain. But it’s believed that higher estrogen levels can lead to more water retention or that some contraceptives may increase appetite. No birth control…
قراءة المزيدAs a nutrition support pharmacist, you will hear more about using Saxenda for weight loss in adolescents 12 and up, not just in adults. Saxenda will be the first GLP-1 agonist for obesity, that in addition to stimulating insulin release and inhibiting glucagon secretion, slows gastric emptying and increases satiety after eating, (see our Note about Saxenda for weigh…
قراءة المزيدMore patients will need help adjusting medications after bariatric surgery. More of these procedures are being done to help patients lose weight, control diabetes, and improve cardiovascular risk. Gastric banding (Lap-Band) and the Roux-en-Y gastric bypass are the most common procedures. Banding uses an inflatable ring to squeeze the neck of the stomach to reduce sto…
قراءة المزيدC linicians often ask about using appetite-stimulating drugs for unintentional weight loss in the elderly. Rapid weight loss in older patients is associated with a higher risk of infection, falls, fractures, and death. Causes of unintentional weight loss in the elderly include disease (e.g., cancer, infection, dental problems), psychiatric illness (e.g., depression, …
قراءة المزيدT he management of obesity is a multifaceted endeavor. Diet, exercise, and behavioral modification are all recommended, in addition to pharmacotherapy when indicated (i.e., individuals with BMI ≥ 27 kg/m² with comorbidity or BMI ≥ 30 kg/m²) or surgical intervention when indicated (i.e., individuals with BMI ≥ 35 kg/m² with comorbidity or BMI ≥ 40 kg/m²). Unfortunat…
قراءة المزيدNPS | Notes in Pharmacy Specialties is a free, open-access, peer-reviewed site focused on pharmacy practice. Articles are immediately accessible, covering clinical pharmacy, pharmaceutical care, health promotion, informatics, and more.
Egypt - Phone: (+20)1210274589
Gmail: abdelwahabward@gmail.com
Social Plugin